MEDIUMVulnerability
Global
Amgen Tells SEC Hack Exposed Patient Data, Trade Secrets
·Source: Bank Info Security
Updated:
Executive Summary
Drug Maker Says PHI, Research, Confidential Business Data Potentially Stolen Pharmaceutical maker Amgen has notified the U.S. Securities and Exchange Commission that cybercriminals have potentially stolen a cache of se
Analysis
Drug Maker Says PHI, Research, Confidential Business Data Potentially Stolen Pharmaceutical maker Amgen has notified the U.S. Securities and Exchange Commission that cybercriminals have potentially stolen a cache of sensitive company data, including patient information, intellectual property, research and development, and other confidential business files.